£36.74

CRC Press Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)

Price data last checked 135 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£37 today · cheaper than every other day in the last 17 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 362 days • 362 data points (No recent data available)

Historical
Generating forecast...
£45.07 £35.91 £37.91 £39.91 £41.90 £43.90 £45.90 01 February 2025 02 May 2025 31 July 2025 29 October 2025 28 January 2026

Price Distribution

Price distribution over 362 days • 6 price levels

Days at Price
Current Price
31 days · current 8 days 260 days 23 days 10 days 30 days 0 65 130 195 260 £37 £39 £42 £43 £44 £45 Days at Price

Price Analysis

Most common price: £42 (260 days, 71.8%)

Price range: £37 - £45

Price levels: 6 different prices over 362 days

Description

Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity’s Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization. Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
31 March 2021
Listed Since
14 October 2020

Barcode

No barcode data available

Similar Products You Might Like

Phase I Oncology Drug Development
97% match

Phase I Oncology Drug Development

Springer

£80.09 08 Mar 2026
Assessing the Economic Value of Anticancer Therapies: 148 (Recent Results in Cancer Research, 148)
97% match

Assessing the Economic Value of Anticancer Therapies: 148 (Recent Results in Cancer Research, 148)

Springer

£77.26 06 Apr 2026
CRC Press Statistical Approaches in Oncology Clinical Development
97% match

CRC Press Statistical Approaches in Oncology Clinical Development

CRC Press

£96.00 18 Apr 2026
Statistical Approaches in Oncology Clinical Development: Current Paradigm and Methodological Advancement (Chapman & Hall/CRC Biostatistics Series)
96% match

Statistical Approaches in Oncology Clinical Development: Current Paradigm and Methodological Advancement (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£54.43 20 Feb 2026
Regulatory and Economic Aspects in Oncology: 213 (Recent Results in Cancer Research, 213)
96% match

Regulatory and Economic Aspects in Oncology: 213 (Recent Results in Cancer Research, 213)

Springer

£87.26 01 Mar 2026
Cancer Chemotherapy: Basic Science to the Clinic
96% match

Cancer Chemotherapy: Basic Science to the Clinic

Wiley-Blackwell

£47.19 16 Feb 2026
Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)
96% match

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Springer

£146.40 25 Jan 2026
Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)
96% match

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

£418.38 11 Jan 2026
Cancer Biology and Therapeutics
96% match

Cancer Biology and Therapeutics

Springer

£148.77 13 Jan 2026
Cancer Biology and Therapeutics
96% match

Cancer Biology and Therapeutics

Springer

£165.87 02 Mar 2026
Wiley Anticancer Therapeutics - Oncology Drug Design Book
96% match

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Wiley

£133.27 15 Apr 2026
The Bethesda Handbook of Clinical Oncology
96% match

The Bethesda Handbook of Clinical Oncology

WOLTERS KLUWER HEALTH

£55.55 12 Mar 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
96% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.09 28 Feb 2026
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)
96% match

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Humana

£149.75 13 Jan 2026
Novel Designs of Early Phase Trials for Cancer Therapeutics
96% match

Novel Designs of Early Phase Trials for Cancer Therapeutics

Academic Press

£95.59 25 Jan 2026
Handbook of Targeted Cancer Therapy and Immunotherapy
96% match

Handbook of Targeted Cancer Therapy and Immunotherapy

WOLTERS KLUWER HEALTH

£54.06 20 Feb 2026
Handbook of Cancer Treatment-Related Symptoms and Toxicities
96% match

Handbook of Cancer Treatment-Related Symptoms and Toxicities

Elsevier

£66.35 12 Jan 2026
Principles of Clinical Cancer Research
96% match

Principles of Clinical Cancer Research

Demos Medical Publishing

£67.71 06 Mar 2026
Evidence–Based Oncology (Evidence–Based Medicine)
96% match

Evidence–Based Oncology (Evidence–Based Medicine)

Wiley-Blackwell

£175.00 23 Jan 2026
Drug Resistance in Cancer Cells
96% match

Drug Resistance in Cancer Cells

Springer

£107.73 08 Apr 2026
You'll Wish You Were an Elephant: Killing Cancer Kindly
96% match

You'll Wish You Were an Elephant: Killing Cancer Kindly

£48.19 09 Feb 2026
Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies
96% match

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

£131.36 14 Jan 2026
Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)
96% match

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Academic Press

£117.19 06 Mar 2026
Methods and Biostatistics in Oncology: Understanding Clinical Research as an Applied Tool
96% match

Methods and Biostatistics in Oncology: Understanding Clinical Research as an Applied Tool

Springer

£99.68 28 Feb 2026